Phase II ABT-888 With Cyclophosphamide
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Primary Peritoneal Cancer|Serous Carcinoma Cancer|Triple-Negative Breast Cancer|Fallopian Tube Cancer
Interventions: DRUG: ABT-888|DRUG: Cyclophosphamide
Sponsor: National Cancer Institute (NCI)